Paweł Burchardt Selected Research

Therapeutics

1/2023	Position of the Polish Cardiac Society on therapeutic targets for LDL cholesterol concentrations in secondary prevention of myocardial infarctions.
12/2021	Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia.
1/2018	Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat.
8/2016	Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness.
1/2013	Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.
1/2012	Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paweł Burchardt Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 02/2014
5	Atrial Fibrillation 04/2024 - 01/2018
4	Hypertension (High Blood Pressure) 04/2024 - 09/2021
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 08/2010
4	Thrombosis (Thrombus) 07/2023 - 01/2017
4	Obesity 01/2022 - 01/2013
3	Myocardial Infarction 01/2023 - 01/2017
3	Diabetes Mellitus 10/2020 - 01/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2013
2	Atrial Flutter (Flutter, Atrial) 04/2024 - 09/2022
2	Atherosclerosis 01/2023 - 01/2011
2	Body Weight (Weight, Body) 09/2022 - 12/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 02/2019
2	Insulin Resistance 01/2018 - 01/2013
1	Infarction (Infarctions) 07/2023
1	Chronic Renal Insufficiency 01/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023
1	Coronary Disease (Coronary Heart Disease) 01/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023
1	Vascular Diseases (Vascular Disease) 01/2023
1	Overweight 09/2022
1	Hemorrhage 05/2022
1	Anemia 12/2021
1	Heart Failure 09/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 12/2020
1	Intermittent Claudication 12/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2020
1	Ischemic Stroke 01/2020
1	Inflammation (Inflammations) 02/2019
1	Unstable Angina 01/2017
1	Weight Loss (Weight Reduction) 08/2016
1	Acute Coronary Syndrome 01/2016
1	Endoleak 07/2015
1	Pain (Aches) 02/2014
1	Atherosclerotic Plaque (Atheroma) 02/2013
1	Ulcerative Colitis 06/2012
1	Neoplasms (Cancer) 06/2012
1	Adenocarcinoma 06/2012
1	Arteriosclerosis 01/2012
1	Stable Angina 01/2012

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 01/2023 - 01/2012
4	oxidized low density lipoproteinIBA 07/2023 - 01/2011
4	Lipoproteins (Lipoprotein)IBA 01/2013 - 01/2011
3	Vitamin D FDA LinkGeneric 04/2024 - 11/2020
3	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2013
3	Insulin (Novolin)FDA Link 01/2018 - 01/2012
2	methyl 4-azidophenylacetimidate (APAI)IBA 04/2024 - 09/2021
2	C-Reactive ProteinIBA 01/2023 - 10/2020
2	AnticoagulantsIBA 12/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2019
2	Cytochrome P-450 CYP2C19IBA 12/2017 - 08/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 01/2012
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2016 - 02/2013
2	LDL glycated lipoproteinsIBA 08/2016 - 01/2013
2	Clopidogrel (Plavix)FDA Link 08/2014 - 02/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2013 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 06/2012 - 01/2012
1	LDL CholesterolIBA 01/2023
1	ElementsIBA 01/2023
1	Long-Acting Thyroid Stimulator (LATS)IBA 09/2022
1	apixabanIBA 05/2022
1	Warfarin (Coumadin)FDA LinkGeneric 12/2021
1	Erythropoietin FDA Link 12/2021
1	Dabigatran FDA Link 12/2021
1	RivaroxabanIBA 12/2021
1	empagliflozinIBA 12/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2021
1	CreatinineIBA 12/2020
1	Calcifediol (Calcidiol)FDA Link 11/2020
1	25-Hydroxyvitamin D 2 (25 Hydroxyvitamin D 2)IBA 11/2020
1	Vitamin K FDA Link 01/2018
1	Cytochrome P-450 CYP3AIBA 12/2017
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	IsoenzymesIBA 08/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2014
1	Tramadol (K315)FDA LinkGeneric 02/2014
1	EstersIBA 02/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2012
1	ApoproteinsIBA 01/2011
1	AntioxidantsIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	Mitochondrial DNA (mtDNA)IBA 08/2010
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 11/2008

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2012
4	Catheter Ablation 04/2024 - 12/2022
3	Electric Countershock (Cardioversion) 07/2023 - 09/2022
2	Stents 12/2020 - 01/2017
1	Secondary Prevention 01/2023
1	Radiofrequency Ablation 01/2023
1	Bariatric Surgery 01/2022
1	Cryosurgery 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Surgical Instruments (Clip) 01/2020
1	Thrombectomy 01/2020
1	Endovascular Aneurysm Repair 07/2015
1	Colonic Pouches (S Pouch) 06/2012